MedTrace Logo

Gabapentin to Reduce Postoperative Nausea and Vomiting

NCT02944981 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2017-05-11

No results posted yet for this study

Summary

The intrathecal administration of morphine is gaining popularity. It is easy to do and can reduce the pain after surgery up to 24 hours. However, it causes postoperative nausea and vomiting more than other methods providing postoperative analgesia. Patients suffering from these side effects have to spend a longer period of time recovering in the hospital with high cost of medical treatment.

Conditions

  • Postoperative Nausea and Vomiting

Interventions

DRUG

Gabapentin

Single oral dose

DRUG

Placebo

Single oral dose

Sponsors & Collaborators

  • Khon Kaen University

    lead OTHER

Principal Investigators

  • Sirirat Tribuddharat, MD · Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2017-02-28
Completion
2017-02-28

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02944981 on ClinicalTrials.gov